Sign in
Sign in
Recover your password.
A password will be e-mailed to you.
HC asks Centre if financial aid for rare diseases covers clinical trials of experimental DMD drug
DMD, one of the various forms of muscular dystrophy, is a rare genetic disease that affects boys almost exclusively and causes…
Azenta to acquire B Medical Systems
The transaction is expected to close in October 2022
Data Integrity Checklist- find the problems in your GMP lab
Compliance with the FDA CFR Part 11, EU Annex 11, and similar regulations has long been a requirement in GMP facilities. Take a…
Vedistry launches Fortyfitt Woman Tablets
The tablets are packed with the potent combination of Soya phytoestrogens and nutraceuticals like green tea, ginseng, grape seed,…
Pfizer to acquire Global Blood Therapeutics for $5.4 billion to enhance presence in rare haematology
Proposed acquisition drives growth by bringing leading sickle cell disease expertise, portfolio and pipeline to Pfizer with…
BioNTech expects Omicron-adapted vaccine deliveries as soon as October
Demand for the vaccine, 3.6 billion doses of which have been shipped globally, is waning as most people in the Western world have…
Datwyler to double capacity at its Indian facility
Datwyler is increasing capacity for all three of its production standards in Pune. The expansion will nearly double capacity and…
CSIR gets first woman Director General in N Kalaiselvi
Known for her work in the field of lithium ion batteries, Kalaiselvi is at present Director of the CSIR-Central Electrochemical…
AstraZeneca’s Savannah phase-II trial shows 49 per cent objective response in lung cancer…
MET is the most common biomarker in patients with EGFR-mutated lung cancer who develop resistance to targetted therapy
Lilly’s Taltz now available in new, citrate-free formulation to reduce injection site pain
Since the medicine's first approval in 2016, nearly 130,000 people in the US have been treated with Taltz